ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance.

Autor: Strillacci A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Biological, Geological and Environmental Sciences, University of Bologna, Bologna, Italy., Sansone P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Children's Cancer and Blood Foundation Laboratories, Weill Cornell Medicine, New York, NY, USA., Rajasekhar VK; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Turkekul M; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boyko V; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Meng F; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Houck-Loomis B; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brown D; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger MF; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hendrickson RC; Microchemistry and Proteomics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chang Q; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pareja F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rajappachetty RS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Del Priore I; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cai Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Penson A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mastroleo C; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berishaj M; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Borsetti F; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Spisni E; Department of Biological, Geological and Environmental Sciences, University of Bologna, Bologna, Italy., Lyden D; Children's Cancer and Blood Foundation Laboratories, Weill Cornell Medicine, New York, NY, USA., Chandarlapaty S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandars@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandars@mskcc.org.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA. chandars@mskcc.org., Bromberg J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bromberj@mskcc.org.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA. bromberj@mskcc.org.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2022 Aug 23; Vol. 8 (1), pp. 96. Date of Electronic Publication: 2022 Aug 23.